CORE - Open-Label Extension Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients with Severe Hypertriglyceridemia (SHTG)

Project: Research

Project Details

StatusActive
Effective start/end date1/11/241/03/25